Oncology Devices Clinical Trial Analysis

Summary

Global Markets Direct's "Oncology Devices Clinical Trials Analysis" is an essential source of data and information pertaining to product clinical trials being carried out by Oncology Devices manufacturers, globally. The report provides exhaustive information on each clinical investigation study with coverage detailed coverage on the pipeline products these trials are being carried out for.

Scope

• The report provides analysis and review of the key clinical trials being carried out globally and across key Oncology Devices market categories - Oncology Devices
• The report covers information on each product being clinically tested with detailed coverage on the pipeline product profile, the indication it's being investigated for etc.
• The report provides an in-depth analysis of the clinical trials with information on trial phase, trial 0status, trial acronym, purpose, inclusion and exclusion criteria, description, design, intervention, investigator information, primary and secondary end-points and trial results
• The report is built using data and information sourced from proprietary databases, primary and secondary research and in house analysis by Global Markets Direct's team of industry experts.

Reasons to Buy

• Effectively plan your Mergers and Acquisitions and partnership strategies by identifying companies with the most promising pipeline.
• Stay ahead of the information curve in the fast changing Oncology Devices market.
• Plan in-licensing and out-licensing opportunities through review of pipeline products and technologies.
• Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
• Proactively plan and execute your competitive strategies by identifying clinical trials status of the leading competitive products in pipeline.
• Stay ahead of competition by understanding the changing competitive landscape in specific geographies.

Contents

• 1 List of Tables
  • 1.1 List of Figures
• 2 Oncology Devices Clinical Trials
  • 2.1 Oncology Devices Clinical Trial By Equipment Type
  • 2.2 Oncology Devices Clinical Trials By Trial Phase and Trial Status
  • 2.3 Oncology Devices Pipeline Products By Development Stage
  • 2.4 Oncology Devices Pipeline Products By Therapy Area
  • 2.5 Oncology Devices Pipeline Products By News Summary
  • 2.6 Oncology Devices ExAblate - Brain
    • 2.6.1 A Feasibility Study To Evaluate The Safety And Feasibility Of Transcranial MRI-Guided Focused Ultrasound Surgery In The Treatment Of Brain Lesions
• 3 Recent Developments
  • 3.1 Product News
    • 3.1.1 Jun 02, 2009: EDAP TMS SA Announces Approval For Ablatherm-HIFU In Argentina
    • 3.1.2 Jun 02, 2009: Sirtex Medical To Present Clinical Data On SIR-Spheres Microspheres At The 2009 ASCO
    • 3.1.3 Jun 01, 2009: Sirtex Medical To Demonstrate SIR-Spheres Microspheres On Upcoming Episode he Economic ReportTelevision Show
    • 3.1.4 May 29, 2009: USPTO Grants Patent To Falcon Genomics' Innovative Cancer Test
    • 3.1.5 May 18, 2009: US FDA Grants Humanitarian Use Designation For BSD-2000 Hyperthermia System
    • 3.1.6 Apr 29, 2009: Ion Beam Applications Receives FDA Clearance For Robotic Patient Positioning System
    • 3.1.7 Apr 15, 2009: BSD Medical Presents Clinical Data On The Use Of Hypothermia Combined With Chemotherapy To Treat Children And Adolescents
    • 3.1.8 Apr 06, 2009: Nanobiotix Demonstrates Pre Clinical Results Of nanoPDT In Treating Glioblastoma Multiforme
    • 3.1.9 Mar 24, 2009: US PTO Issues Patents For Cianna Medical's SAVI Multi-Catheter Brachytherapy Device
    • 3.1.10 Mar 23, 2009: Therakos Receives US FDA Approval For CELLEX Photopheresis System
    • 3.1.11 Mar 11, 2009: New Clue Explains The Link Between Cancer Spread And Diet
    • 3.1.12 Mar 09, 2009: US FDA Grants Clearance To Market Sicel Technologies' DVS-HFT, Dosimeter Calibrated For Use With Radiation Therapy
    • 3.1.13 Mar 05, 2009: BSD Medical Submits Humanitarian Use Petition With FDA For Marketing Clearance For The BSD-2000 Hyperthermia System
    • 3.1.14 Feb 26, 2009: Still River Systems Set To Launch Its Next Generation Proton Therapy System For Cancer Treatment
    • 3.1.15 Feb 17, 2009: Expanded Access Of SAVI Device To Shorter Breast Cancer Therapy
    • 3.1.16 Feb 12, 2009: Nucletron And Advanced Radiation Therapy Enter Into Agreement To Jointly Offer AccuBoost For Image-Guided Breast Irradiation
    • 3.1.17 Feb 06, 2009: Mexican Hospital Installs EDAP's Ablatherm-HIFU Device
    • 3.1.18 Feb 04, 2009: Liuan People's Hospital Installs BSD Medical's Thirteenth BSD-2000 Hyperthermia System
    • 3.1.19 Jan 30, 2009: Elekta's Novel Advanced Radiotherapy Treatment Option Offers New Hope To Russian Cancer Patients
    • 3.1.20 Jan 28, 2009: Therakos Receives Health Canada Approval For THERAKOS CELLEX Photopheresis System
    • 3.1.21 Jan 22, 2009: SAVI Radiation Treatment Now Available With Advanced Radiation Centers Of New York
    • 3.1.22 Dec 24, 2008: Award Winning Technique To Detect Cancer
    • 3.1.23 Dec 18, 2008: IBA Receives FDA Approval For The First Cyclotron-Based Integrated Commercial Proton Therapy System With Pencil Beam Scanning
    • 3.1.24 Oct 08, 2008: BSD Medical To Present Its Systems At China Medical Equipment Fair, Asia's Largest Medical Device Event
    • 3.1.25 Sep 30, 2008: Wake Forest University Baptist Medical Center Ramps Up Cancer Treatment Capabilities With Elekta Axesse
    • 3.1.26 Sep 24, 2008: Study Shows Radiation Device May Customize Therapy, Enable Some To Avoid More Lengthy Treatment
    • 3.1.27 Sep 22, 2008: Nanobiotix's Nanoxray Anticancer Platform Receives European Patent
    • 3.1.28 Sep 15, 2008: Current Opinion In Oncology Highlights Strong Success From Use Of The BSD-2000 In Treating Soft Tissue Sarcomas
    • 3.1.29 Sep 11, 2008: NAS Medical Initiates ClearPath Clinical Experience At Northpoint Cancer Center
    • 3.1.30 Sep 10, 2008: EDAP Installs First Ablatherm Robotic HIFU Device In The Netherlands Continuing European Expansion
    • 3.1.31 Aug 12, 2008: Skagit Valley Hospital Regional Cancer Care Center Enhances Patient Care With Elekta Axesse
    • 3.1.32 Jul 17, 2008: EDAP Announces Initial Ablatherm-HIFU Treatments At Premiere M.D. Anderson Cancer Center In Ongoing Phase II/III Clinical Trial
    • 3.1.33 Feb 13, 2008: Study Results Using The BSD-2000 Presented At International Congress On Anti-Cancer Treatment Held In Paris
  • 3.2 Product Approvals
    • 3.2.1 Jun 02, 2009: EDAP TMS SA Announces Approval For Ablatherm-HIFU In Argentina
    • 3.2.2 May 18, 2009: US FDA Grants Humanitarian Use Designation For BSD-2000 Hyperthermia System
    • 3.2.3 Apr 29, 2009: Ion Beam Applications Receives FDA Clearance For Robotic Patient Positioning System
    • 3.2.4 Mar 23, 2009: Therakos Receives US FDA Approval For CELLEX Photopheresis System
    • 3.2.5 Mar 09, 2009: US FDA Grants Clearance To Market Sicel Technologies' DVS-HFT, Dosimeter Calibrated For Use With Radiation Therapy
    • 3.2.6 Jan 28, 2009: Therakos Receives Health Canada Approval For THERAKOS CELLEX Photopheresis System
    • 3.2.7 Dec 18, 2008: IBA Receives FDA Approval For The First Cyclotron-Based Integrated Commercial Proton Therapy System With Pencil Beam Scanning
  • 3.3 Clinical Trials
    • 3.3.1 Jun 02, 2009: Sirtex Medical To Present Clinical Data On SIR-Spheres Microspheres At The 2009 ASCO
    • 3.3.2 Apr 15, 2009: BSD Medical Presents Clinical Data On The Use Of Hypothermia Combined With Chemotherapy To Treat Children And Adolescents
    • 3.3.3 Feb 17, 2009: Expanded Access Of SAVI Device To Shorter Breast Cancer Therapy
    • 3.3.4 Sep 24, 2008: Study Shows Radiation Device May Customize Therapy, Enable Some To Avoid More Lengthy Treatment
    • 3.3.5 Sep 11, 2008: NAS Medical Initiates ClearPath Clinical Experience At Northpoint Cancer Center
    • 3.3.6 Jul 17, 2008: EDAP Announces Initial Ablatherm-HIFU Treatments At Premiere M.D. Anderson Cancer Center In Ongoing Phase II/III Clinical Trial
• 4 Appendix
  • 4.1 Methodology
    • 4.1.1 Coverage
    • 4.1.2 Secondary Research
    • 4.1.3 Primary Research
    • 4.1.4 Expert Panel Validation
  • 4.2 Contact Us
  • 4.3 About Global Markets Direct
  • 4.4 Disclaimer
• 1 List of Tables
  • Table 1: Oncology Devices Clinical Trial By Equipment Type
  • Table 2: Oncology Devices Clinical Trials By Trial Phase and Trial Status
  • Table 3: Oncology Devices Pipeline Products By Development Stage
  • Table 4: Oncology Devices Pipeline Products By Therapy Area
  • Table 5: Oncology Devices Pipeline Products By News Summary
  • Table 6: ExAblate - Brain - A Feasibility Study To Evaluate The Safety And Feasibility Of Transcranial MRI-Guided Focused Ultrasound Surgery In The Treatment Of Brain Lesions
• 1.2 List of Figures
  • Figure 1: Global Markets Direct Methodology